Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 37 filings·Updated 28 Sept 2026
Showing 10 of 37 filings.
28 Sept 20261 filing
Insider Trading / SASTClosure of Trading Window

Kriti Nutrients Ltd — Closure of Trading Window

Kriti Nutrients Ltd — Closure of Trading Window

Filed 12:22View Source
15 Sept 20261 filing
Company UpdateReply to Clarification- Financial results

Kriti Nutrients clarifies LRR header format for quarterly results

Compliance Update

  • Heading of accompanying statement is 'STATEMENT OF UNAUDITED STANDALONE AND CONSOLIDATED FINANCIAL RESULTS'.
  • Requests NSE to drop the observation and take no further action.
Filed 17:51View Source
9 Sept 20261 filing
AGM/EGMAGM

Kriti Nutrients' 30th AGM held via VC/OAVM on 12 August 2026; all resolutions passed with interim dividend approved

AGM Details

  • Date and mode: 12 August 2026, VC/OAVM; no physical attendance.
  • Quorum: 30; 49 members attended via video conference.
  • Cut-off date: 5 August 2026; members on cut-off: 19,740.
  • Remote voting: 9–11 August 2026; results declared within 2 days.
  • Meeting concluded at 5:01 PM.

Key Resolutions

  • Ordinary 1: Adoption of audited standalone and consolidated financial statements.
  • Ordinary 2: Interim dividend of Rs 3.00 per share confirmed.
  • Ordinary 3: Re-appointment of Saurabh Singh Mehta by rotation.
  • Ordinary 4: Re-appointment of M/s M Mehta & Co as Statutory Auditors.
  • Ordinary 5: Ratification of Cost Auditors’ remuneration for 2026-27.
  • Special 6: Remuneration revision for Saurabh Mehta as WTD/JMD; cap may exceed 5%.
  • Special 7: Reappointment of Shiv Singh Mehta as Chairman & MD for 2027–2030.
  • Special 8: Reappointment of Saurabh Mehta as WTD/JMD for 2027–2030; remuneration terms.

Voting Results

  • All resolutions passed by requisite majority; Scrutiniser’s report dated 13 August 2026.
  • Res 1: Passed; ordinary resolution.
  • Res 2: Passed; interim dividend approved.
  • Res 3: Passed; re-appointment by rotation.
  • Res 4: Passed; statutory auditors re-appointed.
  • Res 5: Passed; cost auditors’ remuneration ratified.
  • Res 6: Passed; special resolution on remuneration above cap.
  • Res 7: Passed; special resolution for MD appointment.
  • Res 8: Passed; special resolution for WTD/JMD appointment.

Dividend

  • Interim dividend of Rs 3.00 per equity share approved (for FY 2025-26).

Director Changes

  • Saurabh Singh Mehta re-appointed by rotation.
  • Shiv Singh Mehta re-appointed as Chairman and MD for 2027–2030.
  • Saurabh Singh Mehta re-appointed as WTD/JMD for 2027–2030.

Auditor Appointments

  • M/s Mehta & Co re-appointed as Statutory Auditors for 2026-27 to 2031.
  • Remuneration for Cost Auditors Rs 35,000 ratified.

Related Party Transactions

  • No material related party transactions disclosed.

Other Material Approvals

  • Remuneration revisions for directors may exceed 5% of net profits; Board discretion granted.
Filed 15:28View Source
31 Aug 20261 filing
Company UpdateClarification - Financial Results

The Exchange has sought clarification from Kriti Nutrients Limited for the quarter ended 30-Jun-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: The response of the Company is awaited.

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 17:53View Source
14 Aug 20263 filings
Company UpdateChange in Management

Kriti Nutrients approves reappointment of statutory auditor and executive directors at AGM 2026

Statutory Auditor Reappointment

  • Reappointment of M/s M. Mehta & Company as Statutory Auditors.
  • Term: five years from 12 Aug 2026 to AGM 2031.
  • Profile: Indore-based CA firm with extensive statutory audits.
  • Reason: Reappointment.

Chairman & Managing Director Reappointment

  • Reappointment of Shiv Singh Mehta as Chairman and Managing Director.
  • Date of appointment: 12 August 2026.
  • Term: three years from 12 Jan 2027 to 11 Jan 2030.
  • Profile: BE Electrical Eng; MBA; founder and promoter.
  • Relationships: Relative of wife Purnima Mehta and son Saurabh Mehta.
  • Not debarred by SEBI.

Joint Managing Director Reappointment

  • Reappointment of Saurabh Singh Mehta as Whole Time Director (Joint Managing Director).
  • Date of appointment: 12 August 2026.
  • Term: three years from 1 Aug 2027 to 31 Jul 2030.
  • Profile: BE Computer Science; MBA in Family Business; 13 years' experience.
  • Relationships: Son of Shiv Singh Mehta and Purnima Mehta.
  • Not debarred by SEBI.
Filed 18:41View Source
Company UpdateGeneral

Kriti Nutrients AGM approves financials, dividend, and board remuneration changes

AGM outcomes

  • Adoption of Audited standalone and consolidated financial statements for year ended 31 March 2026.
  • Interim dividend Rs 3.00 per share on 5,01,03,520 equity shares.
  • Re-appointment of Saurabh Singh Mehta who retires by rotation.
  • Re-appointment of M Mehta & Company as statutory auditors.
  • Ratification of remuneration payable to Dhananjay V. Joshi & Associates for 2026-27.
  • Revision in remuneration of Saurabh Singh Mehta as Whole-time Director and Joint MD.
  • Reappointment and remuneration of Shiv Singh Mehta as Chairman and Managing Director.
  • Reappointment and remuneration of Saurabh Singh Mehta as WTD designated as Joint MD.
Filed 13:24View Source
AGM/EGMAGM

Kriti Nutrients AGM 2026 approves interim dividend, director re-appointments, and remuneration approvals via VC

AGM details

  • AGM held on 12 August 2026 at 4:30 PM via video conferencing.
  • Venue deemed at Indore address; meeting conducted online.
  • Promoter group and public attendees participated via VC.

Resolutions

  • Resolution 1: Adoption of financial statements and directors' and auditors' reports.
  • Resolution 2: Interim dividend for FY 2025-26 approved.
  • Resolution 3: Re-appointment of Mr. Saurabh Singh Mehta as Director.
  • Resolution 4: Re-appointment of statutory auditors M/s Mehta & Co.
  • Resolution 5: Ratification of remuneration for Cost Auditor FY 2026-27.
  • Resolution 6: Special: Re-appointment of Whole-time Director and remuneration.
  • Resolution 7: Special: Re-appointment of Chairman and Managing Director; remuneration fixed.

Voting results

  • All ordinary resolutions passed; strong promoter support.
  • Resolution 6 showed public opposition around 1.6%.
  • Resolution 7 passed with high overall support; minimal public opposition.

Dividend

  • Interim dividend for FY 2025-26 approved; per-share amount not disclosed.

Directors

  • Mr. Saurabh Singh Mehta re-appointed as Director.

Auditors

  • Statutory auditors re-appointed: M/s Mehta & Co.

Other material approvals

  • Remuneration approvals for senior managerial appointments as part of AGM.
Filed 13:12View Source
13 Aug 20261 filing
Company UpdateNewspaper Publication

Newspaper publication of Unaudited Standalone and Consolidated Financial Results for the Quarter ending 30th June,2026.

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 15:03View Source
12 Aug 20261 filing
Company UpdateGeneral

Kriti Nutrients 30th AGM held via VC/OAVM; financials adopted, dividend approved, governance actions taken

AGM Proceedings and Key Outcomes

  • 30th AGM held Aug 12, 2026 via VC/OAVM; proceedings submitted per SEBI LODR.
  • E-voting completed Aug 11; results to be communicated within two working days after Scrutinizer's Report.
  • Ordinary business: adoption of standalone and consolidated financial statements for year ended 31 March 2026.
  • Interim dividend of Rs 3.00 per share approved as final for FY25-26; total Rs 1503.11 Lakhs.
  • Saurabh Singh Mehta re-appointed as Joint Managing Director for 1 Aug 2027 to 31 Jul 2030.
  • Shiv Singh Mehta re-appointed as Chairman and Managing Director for 12 January 2027 to 11 January 2030.
  • Statutory Auditor M/s M Mehta & Company re-appointed for the second consecutive five-year term (2026-2031).
  • Cost Auditor remuneration of Rs 35,000 plus taxes approved for FY2026-27.
  • Remuneration framework approvals for top executives were approved per board.
Filed 19:40View Source
11 Aug 20261 filing
ResultFinancial Results

Kriti Nutrients reports Q1 FY27 unaudited standalone and consolidated results; revenue Rs 24,707.76 lakh, PAT Rs 905.66 lakh.

Standalone results

  • Standalone revenue from operations: Rs 24,707.76 lakh for Q1 FY27.
  • Total standalone revenue: Rs 24,875.11 lakh.
  • Standalone net profit after tax: Rs 905.66 lakh.
  • EPS (basic/diluted): Rs 1.81 per share.
  • Cost of materials consumed: Rs 20,107.84 lakh.
  • Employee benefits expense: Rs 414.25 lakh.
  • Finance costs: Rs 23.81 lakh.
  • Depreciation and amortization: Rs 151.70 lakh.
  • Board approved results at meeting on 11 Aug 2026.

Consolidated results

  • Consolidated revenue from operations: Rs 24,707.76 lakh.
  • Consolidated total revenue: Rs 24,875.11 lakh.
  • Consolidated net profit after tax: Rs 905.66 lakh.
  • Consolidated EPS: Rs 1.78 per share.
  • Associate Kriti Industries (India) Limited accounted under equity method; results unreviewed.

Other details

  • Single operating segment: Oil Seed Extraction and Refining.
  • Associate company: Kriti Industries (India) Limited; equity method.
  • Auditors' review reports: unmodified opinion.
Filed 17:05View Source
Showing 10 of 37 filings